Follow
David Toledo-Aparicio
David Toledo-Aparicio
Associate Scientist at Johnson & Johnson Innovative Medicine
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Predicting bacterial promoter function and evolution from random sequences
M Lagator, S Sarikas, M Steinrueck, D Toledo-Aparicio, JP Bollback, ...
Elife 11, e64543, 2022
162022
Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa
DJ Fraser-Pitt, SK Dolan, D Toledo-Aparicio, JG Hunt, DW Smith, ...
Frontiers in Cellular and Infection Microbiology 11, 718213, 2021
82021
Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection
D Fraser-Pitt, DK Mercer, ML Francis, D Toledo-Aparicio, DW Smith, ...
Biochemical and Biophysical Research Communications 677, 168-181, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–3